Identificación de riesgo de progresión de la enfermedad de Parkinson utilizando Machine Learning

Ana Carolina Rincón Velásquez

doi:10.24050/reia.v22i43.1841

Identification of Parkinson’s disease progression risk using Machine Learning

10.24050/reia.v22i43.1841

Published 2025-01-01

Articles

How to Cite

Identification of Parkinson’s disease progression risk using Machine Learning (A. C. Rincón Velásquez, Trans.). (2025). Revista EIA, 22(43), 4304 pp. 1-17. https://doi.org/10.24050/reia.v22i43.1841

Download Citation

Publication Data

License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright statement

The authors exclusively assign to the Universidad EIA, with the power to assign to third parties, all the exploitation rights that derive from the works that are accepted for publication in the Revista EIA, as well as in any product derived from it and, in in particular, those of reproduction, distribution, public communication (including interactive making available) and transformation (including adaptation, modification and, where appropriate, translation), for all types of exploitation (by way of example and not limitation : in paper, electronic, online, computer or audiovisual format, as well as in any other format, even for promotional or advertising purposes and / or for the production of derivative products), for a worldwide territorial scope and for the entire duration of the rights provided for in the current published text of the Intellectual Property Law. This assignment will be made by the authors without the right to any type of remuneration or compensation.

Consequently, the author may not publish or disseminate the works that are selected for publication in the Revista EIA, neither totally nor partially, nor authorize their publication to third parties, without the prior express authorization, requested and granted in writing, from the Univeridad EIA.

Abstract Authors References Statistics

Abstract

Background: Parkinson’s Disease (PD) affects the lives of patients in different ways, who initially do not know what the progression of the disease will be like in the coming years and the changes it will imply in their life plans. The objective of this study is to implement a Parkinson’s progression risk prediction model using autonomous learning techniques.
Methodology: 11 variables are selected that are used in other related studies and are taken from clinical data of patients with PD captured through evaluations and questionnaires. Prediction models
are implemented using Machine Learning techniques: Logistic Regression, Random Forest and Gradient Boosting Machine (GBM).
Performances are evaluated through the area under the Receiver Operating Characteristic (ROC) curve.
Results: A set of data with quality and according to the needs of the case study is obtained using the PPMI database with which a robust model of risk of PD progression is implemented over a period of 10 years, with an area under the curve (AUC) of
0.9, interpretable, reliable and with high usability for patients, caregivers and qualified personnel who will be able to make more accurate decisions from the data.

Keywords

Authors

Ana Carolina Rincón Velásquez

Colombia

References

Castro Toro Aracelly, Buriticá Omar Freddy. (2014). Enfermedad de parkinson: criterios diagnósticos, factores de riesgo y de progresión, y escalas de valoración del estadio clínico. http://www.scielo.org.co/pdf/anco/v30n4/ v30n4a10.pdf.

DAMA International. (2017). Data Management Body of Knowledge. Second Edition. Basking Ridge, NJ 07920 USA: Technics Publications.

De Jong Johann, Emon Mohammad Asif, Wu Ping, Karki Reagon, Sood Meemansa, Godard Patrice, Ahmad Ashar, Vrooman Henri, Hofmann-Apitius Martin, Holger Fröhlich. (2019). Deep learning for clustering of multivariate clinical patient trajectories with missing values. GigaScience, Volume 8, Issue 11, November 2019, giz134, https://doi.org/10.1093/gigascience/giz134.

Drew Daniel S, Muhammed Kinan, Baig Fahd, Kelly Mark, Saleh Youssuf, Sarangmat Nagaraja, Okai David, Hu Michele, Manohar Sanjay and Husain Masud. (2020). Dopamine and reward hypersensitivity in Parkinson’s disease with impulse control disorder. https://doi.org/10.1093/brain/awaa198.

Espinosa-Zúñiga, Javier Jesús. (2020). Aplicación de algoritmos Random Forest y XGBoost en una base de solicitudes de tarjetas de crédito. Ingeniería, investigación y tecnología, 21(3), 00002. Epub 02 de diciembre de 2020. https://doi.org/10.22201/fi.25940732e.2020.21.3.022

Evans, A. H., Okai, D., Weintraub, D., Lim, S. -Y., O’Sullivan, S. S., Voon, V., Krack, P., Sampaio, C., Post, B., Leentjens, A. F. G., Martinez-Martin, P., Stebbins, G. T., Goetz, C. G., Schrag, A., Bhidayasiri, R., Brown, R. G., Marinus, J., Mestre, T. A., Violante, M. R. & Skorvanek, M. (2019). Scales to assess impulsive and compulsive behaviors in Parkinson’s disease: Critique and recommendations. https://doi.org/10.1002/mds.27689.

Fuentes-Arderiu, X. (2013). What is a biomarker? It’s time for a renewed definition. Clinical Chemistry and Laboratory Medicine, Vol. 51 (Issue 9), pp. 1689- 1690. https://doi.org/10.1515/cclm-2013-0240.

Fundación Michael J. Fox. About Parkinson’s. (2024). https://www.michaeljfox.org/ parkinsons-101.

Gerraty RT, Provost A, Li L, Wagner E, Haas M and Lancashire L. (2023). Machine learning within the Parkinson’s progression markers initiative: Review of the current state of affairs. doi: 10.3389/fnagi.2023.1076657

Gramotnev, G., Gramotnev, D.K. & Gramotnev, A. (2021). Publisher Correction: Parkinson’s disease prognostic scores for progression of cognitive decline. Sci Rep 11, 5915. https://doi.org/10.1038/s41598-020-76437-z.

International Parkinson and Movement Disorder Society (MDS). MDS-UPDRS. (2019).

International Parkinson and Movement Disorder Society. MDS-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS). (2024) https://www.movementdisorders. org/MDS/MDS-Rating-Scales/MDS-Unified-Parkinsons-Disease-Rating-Scale- MDS-UPDRS.htm.

Johns MW. (1991). A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep. https://nasemso.org/wp-content/uploads/neuro-epworthsleepscale.pdf.

Martínez-Martín P, Rodríguez-Blázquez C, Mario Alvarez, Arakaki T, Arillo VC, Chaná P, Fernández W, Garretto N, Martínez-Castrillo JC, Rodríguez- Violante M, Serrano-Dueñas M, Ballesteros D, Rojo-Abuin JM, Chaudhuri KR, Merello M. (2015). Parkinson’s disease severity levels and MDS-Unified Parkinson’s Disease Rating Scale. Parkinsonism Relat Disord. doi: 10.1016/j. parkreldis.2014.10.026.

McEwen Barbara. (2023). Administering the MoCA: What Does it Mean and Why is it Important?.https://rivcodpss.org/sites/g/files/aldnop276/files/2023-04/ MoCA%20Presentation.FULL%20PAGE.pdf.

Mohammad R. Salmanpour, Mojtaba Shamsaei, Abdollah Saberi, Saeed Setayeshi, Ivan S. Klyuzhin, Vesna Sossi, Arman Rahmim. (2019). Optimized machine learning methods for prediction of cognitive outcome in Parkinson’s disease. https://doi.org/10.1016/j.compbiomed.2019.103347.

Nalls Mike A, Keller Margaux F, Hernandez Dena G, Chen Lan, Stone David J, Singleton Andrew B. (2016). Baseline genetic associations in the Parkinson’s Progression Markers Initiative (PPMI). doi: 10.1002/mds.26374.

Nguyen Alex A., Maia Pedro D., Gao Xiao, Damasceno Pablo F., and Raj Ashish. (2020). “Dynamical Role of Pivotal Brain Regions in Parkinson Symptomatology Uncovered with Deep Learning” Brain Sciences 10, no. 2: 73. https://doi. org/10.3390/brainsci10020073.

NIH. Form Structure: PDBP Modified Schwab and England Scale - Legacy Data. (2015). https://fitbir.nih.gov/dictionary/publicData/ dataStructureAction!lightboxView.ajax?dataStructureName=LD_ ModSchwabEnglandScale&publicArea=true.

Nomura Takashi, Inoue Yuichi, Kagimura Tatsuo, Uemura Yusuke, Nakashima Kenji. (2011). Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson’s disease patients. doi: 10.1016/j.sleep.2011.01.015.

Orozco, J. L., Valderrama-Chaparro, J. A., Pinilla-Monsalve, G. D., Molina- Echeverry, M. I., Pérez Castaño, A. M., Ariza-Araújo, Y., Prada, S. I., & Takeuchi, Y. (2020). Parkinson’s disease prevalence, age distribution and staging in Colombia. Neurology international, 12(1), 8401. https://doi.org/10.4081/ ni.2020.8401.

Parkinson’s Progressive Markers Initiative (PPMI). (2023). Data User Guide – updated August 22nd, 2023. PPMI Dataset.

Schrag Anette, Siddiqui Uzma Faisal, Anastasiou Zacharias, Weintraub Daniel, Schott Jonathan M. (2017). Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson’s disease: a cohort study. https://doi.org/10.1016/S1474-4422(16)30328-3.

Section. (2024). How to Analyze Machine Learning Models using SHAP. https:// www.section.io/engineering-education/how-to-analyze-machine-learning-models-using-shap/.

Tang Chunyan, Zhao Xiaoyan, Wu Wei, Zhong Weijia, Wu Xiaojia. (2021). An individualized prediction of time to cognitive impairment in Parkinson’s disease: A combined multi-predictor study. https://doi.org/10.1016/j. neulet.2021.136149.

Statistics

Abstract

0

PDF accesses

0

Dimensions

PlumX

Downloads

Download data is not yet available.

Appearance

Language

Navigation

User

Identification of Parkinson’s disease progression risk using Machine Learning

Abstract

Keywords

Categories

Authors

Ana Carolina Rincón Velásquez

References

Statistics

Dimensions

PlumX

Downloads